Diabetes patients tend to overestimate complications risk, treatment benefits.

In your practice, are you seeing more or less patients with prediabetes and diabetes? Follow the link to respond.

A 51-year-old patient returns to your office for a follow-up visit. She is currently taking metformin and glipizide after being diagnosed with type 2 diabetes eight years ago. She shows you her self-care logs that indicate she has been eating a healthy diet and walking daily. She has been maintaining her weight (BMI 26kg/m2). Despite her excellent efforts, her A1C is 7.8%, above her target of A1C<7.0%. When you start to discuss adding a basal insulin dose to her regimen, she bursts into tears. All of the following are common barriers to insulin therapy initiations EXCEPT (follow the link to answer):

How does one address holiday temptation without going overboard health-wise?

21, 28, 30, 90. What do these numbers mean? For many of us they are the number of days before leftover insulin has to be thrown away. As a pharmacist it often amazes me what patients think they should do. If you need the quick answer for your patients be …

In the Look AHEAD study, about 15% had symptoms of mild–moderate depression, about 17% were current users of antidepressant medication, and about 4% both [13]. Other studies in the USA have described higher rates, up to 25%, of more severe depression, with all ethnic groups (white, African-American, Latinos and others) recording similar rates.

In this week's Homerun Slides, the effect of dapagliflozin on endogenous glucose production, plasma insulin and glucagon concentration.

Diabetes in Control Publisher Steve Freed meets with Dr. Richard Bergman at the 75th ADA Scientific Sessions in Boston. In this first installment, Dr. Bergman shares his start in diabetes research and explains the high points of his presentation, Comparative Methods for Assessment of Insulin Sensitivity: Oral Vs. Intravenous. Dr. Richard Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

When we talk about the causes of diabetes we know it is not just one thing; in fact the Ominous Octet is a phrase that is often used to describe the defects that play a role in diabetes. The first and most well-known of these is insulin resistance. In fact …

Diabetes In Control readers submitted their best advice on how to prevent insulin errors at home, at pharmacies, and in the hospital. We're happy to present the winning entry, by Joyce Larson, as well as a selection of other excellent entries.